Skip to main content
Log in

Gilead negotiates with Indian generic companies over sofosbuvir

  • News item
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. The price for sofosbuvir in the US is $84 000 for a 12-week treatment course.

Reference

  • Hirschler B. Gilead aims to license hepatitis C drug to 3-4 Indian firms. Internet Document : 10 Apr 2014. Available from: URL: http://www.reuters.com

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gilead negotiates with Indian generic companies over sofosbuvir. PharmacoEcon Outcomes News 701, 8 (2014). https://doi.org/10.1007/s40274-014-1206-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-014-1206-3

Navigation